株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の腫瘍切除市場調査と予測

Global Tumor Ablation Market Research and Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 762918
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.34円で換算しております。
Back to Top
世界の腫瘍切除市場調査と予測 Global Tumor Ablation Market Research and Forecast, 2018-2023
出版日: 2018年12月07日 ページ情報: 英文
概要

当レポートでは、世界の腫瘍切除市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査サマリー

第2章 市場概要と考察

  • 定義
  • アナリストの考察と現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 法規制

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • 技術別市場
    • 高周波アブレーション
    • マイクロ波アブレーション
    • 凍結アブレーション
    • 経皮的エタノールアブレーション
  • 用途別市場
    • 肝癌
    • 肺癌
    • 乳癌
    • 前立腺癌
    • その他
  • エンドユーザー別市場
    • 病院
    • 外科クリニック
    • 研究機関

第5章 競合環境

  • 主な戦略分析
  • 主要企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 企業のプロファイル

図表

List of Tables

  • TABLE # 1 GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 2 GLOBAL RADIO FREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 3 GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 4 GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 5 GLOBAL PERCUTANEOUS ETHANOL ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 6 GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023($ MILLION)
  • TABLE # 7 GLOBAL LIVER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 8 GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 9 GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 10 GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 11 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 12 GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 13 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 14 GLOBAL SURGICAL CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 15 GLOBAL RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 16 GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023($ MILLION)
  • TABLE # 17 NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION
  • TABLE # 18 NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 19 NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023($ MILLION)
  • TABLE # 20 NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
  • TABLE # 21 EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
  • TABLE # 22 EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 23 EUROPE TUMOR ABLATION MARKET, MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023($ MILLION)
  • TABLE # 24 EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 25 ASIA-PACIFIC TUMOR ABLATION, MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
  • TABLE # 26 ASIA-PACIFIC TUMOR ABLATION, MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023($ MILLION)
  • TABLE # 27 ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023($ MILLION)
  • TABLE # 28 ASIA PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023($ MILLION)
  • TABLE # 29 REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
  • TABLE # 30 REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
  • TABLE # 31 REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL TUMOR ABLATION MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL TUMOR ABLATION MARKET SHARE BY APPLICATION, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL TUMOR ABLATION MARKET SHARE BY END-USER, 2017 VS 2023 (%)
  • FIGURE # 4 GLOBAL TUMOR ABLATION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 5 UNITED STATES TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 EUROPE TUMOR ABLATION MARKET SIZE, 2017-2023($ MILLION)
  • FIGURE # 8 UK TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 GERMANY TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 SPAIN TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 FRANCE TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 ITALY TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 ROE TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 CHINA TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 INDIA TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 JAPAN TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 REST OF ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 18 REST OF THE WORLD TUMOR ABLATION MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018442

Tumor ablation is the technology used for destroying the tumor which can be done by using imaging technology to place the needle into the tumor organ. The treatment can be done by using various technologies such as radiofrequency ablation, microwave ablation, cryoablation, and other such technologies. There are various cancers that can be treated by this technology such as lung cancer, liver tumor, prostate cancer, kidney tumor, and other tumors. The increasing incidence of cancer and the rising aging population is the major growth factors for this market. Moreover, high efficacy and safety are majorly contributing to the growth.

The government and healthcare authorities are very much concern for using radio and microtechnology due to the side effects associated with it. Hence, it can hinder the growth of the tumor ablation market. However, the research and development in ablation technology for treating the primary breast cancer and adrenal neoplasm, as well as the improvement in imaging technology will fuel the growth of the market in future. Furthermore, the adoption of minimally invasive therapy will increase the usage of this technology and create a huge opportunity for this market.

Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. The developed healthcare infrastructure and increasing healthcare expenditure make the North American region, a dominating market. in addition, the prevalence of cancer in the US further fuel the growth of the market as advanced ablation technologies is needed for destroying the cancerous cells. Asia Pacific is expected to have the highest CAGR in this market due to the improvement in the healthcare industry and the government support for adopting such technology.

There are many companies which are operating in tumor ablation market such as HealthTronics, Inc, Cortex Technology, Cooper Surgical Inc, AtriCure, Inc., Galil Medical Inc., Endocare, Inc., and Integra LifeSciences Holdings Corporation. The companies are working on the development of innovative technologies. In addition, these players have adopted inorganic growth strategies to remain competitive in the market. For an instance: Galil Medical has signed an agreement in October 2017, for the acquisition of Perseon Corporation.

Research methodology

The market study of tumor ablation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include

  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the American Cancer Society, National Cancer Institute, OECD, WHO, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.

The report is intended for the tumor ablation equipment manufacturer, healthcare providers, investing companies, emerging companies, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market segmentation

Global Tumor Ablation market is segmented on the basis of regional outlook and following segments:

1. Global Tumor Ablation Market Research and Analysis, By Technology

2. Global Tumor Ablation Market Research and Analysis, By Application

3. Global Tumor Ablation Market Research and Analysis, By End-User

4. Global Tumor Ablation Market Research and Analysis, By Region

THE REPORT COVERS

  • Comprehensive research methodology of global tumor ablation
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the
  • Global tumor ablation market.
  • Insights about market determinants which are stimulating the global tumor ablation
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendation
    • 2.2.3. Conclusion
  • 2.3. Regulation

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Increasing Incidence of Cancer Diseases
    • 3.1.2. Increasing Demand for Minimally Invasive Surgery
    • 3.1.3. Technological Advancement in Ablation Devices
    • 3.1.4. Increasing Healthcare Expenditure
  • 3.2. Restraints
    • 3.2.1. Lack of Skilled Practitioners
    • 3.2.2. Stringent Government Regulations
  • 3.3. Opportunities
    • 3.3.1. Ongoing Research on Tumor Ablation
    • 3.3.2. Cryoablation In Clinical Trials
    • 3.3.3. Inorganic Growth Strategies Adopted by The Players

4. Market Segmentation

  • 4.1. Global Tumor Ablation Market by Technology
    • 4.1.1. Radio Frequency Ablation
    • 4.1.2. Microwave Ablation
    • 4.1.3. Cryoablation
    • 4.1.4. Percutaneous Ethanol Ablation
  • 4.2. Global Tumor Ablation Market by Application
    • 4.2.1. Liver Cancer
    • 4.2.2. Lung Cancer
    • 4.2.3. Breast Cancer
    • 4.2.4. Prostate Cancer
    • 4.2.5. Others
  • 4.3. Global Tumor Ablation Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Surgical Clinics
    • 4.3.3. Research Institutions

5. Competitive Landscape

  • 5.1. Key Strategies
  • 5.2. Key Company Analysis

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Spain
    • 6.2.4. France
    • 6.2.5. Italy
    • 6.2.6. RoE
  • 6.3. Asia-Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Adagio Medical, Inc.
  • 7.2. Afreeze GmbH
  • 7.3. Alpinion Medical Systems Co., Ltd.
  • 7.4. Arrinex, Inc.
  • 7.5. Atricure, Inc.
  • 7.6. ATS Medical, Inc.
  • 7.7. Biosig Technologies, Inc.
  • 7.8. Biotronik, Inc.
  • 7.9. Boston Scientific Corp.
  • 7.10. BTG Plc
  • 7.11. BVM Medical Ltd
  • 7.12. C2 Therapeutics, Inc.
  • 7.13. Coopersurgical Inc.
  • 7.14. Endocare, Inc.
  • 7.15. Erbe Elektromedizin GmbH
  • 7.16. Galil Medical Inc
  • 7.17. Healthtronics, Inc.
  • 7.18. Icecure Medical Ltd
  • 7.19. Integra Lifesciences Holdings Corp.
  • 7.20. Koninklijke Philips N.V
  • 7.21. Medtronic Plc
  • 7.22. Medwaves Inc.
  • 7.23. Sanarus Technologies, Inc.
Back to Top